Malwarebytes has announced the acquisition of vulnerability, exploit and security research and development firm. ZeroVulnerabilityLabs.
The anti-malware company said that the acquisition will add functions to its offering including proactively shielding software applications from known and zero-day exploits used by exploit kits, web-based vulnerability exploits and other corporate-targeted attacks.
Malwarebytes will also acquire the ExploitShield product, which it claimed prevents drive-by download attacks originating from commercial exploit kits
Marcin Kleczynski, CEO of Malwarebytes “We are always looking to improve upon our existing offerings, and have done so with the addition of ZeroVulnerabilityLabs' technology. The proactive nature of this technology makes it a great addition and compliment to the existing Malwarebytes software suite.”
Pedro Bustamante, co-founder and CEO of ZeroVulnerabilityLabs, said: “We are excited to be joining the Malwarebytes team and to work to advance the latest anti-exploit R&D efforts, which we started at ZeroVulnerabilityLabs.
.png&h=140&w=231&c=1&s=0)
_(5).jpg&h=140&w=231&c=1&s=0)
.png&h=140&w=231&c=1&s=0)
.png&w=100&c=1&s=0)
Digital NSW 2025 Showcase
_(1).jpg&h=140&w=231&c=1&s=0)
